Health ❯ Mental Health ❯ Depression

Treatment Options

Psychedelic Therapy Personalized Medicine Support Systems Ketamine Therapy Counseling Services Crisis Intervention Stigma in Military Stigma Navacaprant Ketamine and Microdosing Clinical Research Lycopene Support Resources Antidepressants Psychedelic-like Treatments Exercise Ketamine Exercise as Treatment Cognitive Behavioral Therapy Exercise vs Antidepressants Exercise and Medicine Combination Psilocybin Efficacy Esketamine Social Prescriptions Mindfulness-Based Cognitive Therapy Medication Side Effects Tianeptine Ketamine Treatment SSRIs Psychiatry Antidepressant Medications Over-the-Counter Products Over-the-Counter Remedies Healthcare Costs Innovative Therapies Dietary Interventions Ozempic Personal Stories Citalopram Caplyta Personalized Treatment Sertraline Alternative Therapies Antidepressant Side Effects Unapproved Drugs Psilocybin-Assisted Therapy Social Prescribing

FDA Approves J&J’s Caplyta for Major Depressive Disorder

The clearance bolsters J&J’s neuroscience strategy following its $14.6 billion Intra‑Cellular Therapies acquisition.

The Lancet Review Finds Antidepressants Differ Sharply in Weight, Heart Rate and Blood Pressure Effects